Xalatan - Comprehensive Usage Guide: instructions, indications, composition, side effects
Composition
Active Ingredient: Latanoprost
Excipients: May include benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, and other inactive ingredients depending on the formulation.
Official Forms
Eye Drops: Available in a concentration of 0.005% latanoprost.
Pharmacological Group
Xalatan belongs to the pharmacological group of prostaglandin analogs (ATC code: S01E E01).
Pharmacological Properties
- Pharmacodynamics: Latanoprost is a prostaglandin F2alpha analog that reduces intraocular pressure (IOP) by increasing the outflow of aqueous humor through the uveoscleral pathway.
- Pharmacokinetics: After ocular administration, latanoprost is absorbed through the cornea and hydrolyzed to the active form. Peak plasma concentrations are reached within 2 hours. It is metabolized in the liver and excreted primarily in the urine.
Indications
Xalatan is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Contraindications
Xalatan is contraindicated in individuals with:
- Hypersensitivity to latanoprost or any component of the formulation.
- Active intraocular inflammation (e.g., uveitis).
- Aphakia.
Interactions
Xalatan may interact with other medications, including:
- Prostaglandin analogs, beta-blockers, or carbonic anhydrase inhibitors, potentially leading to additive effects on intraocular pressure reduction.
- Contact lenses should be removed before administration and may be reinserted after 15 minutes.
Specifics of Use
- Xalatan eye drops should be instilled into the affected eye(s) according to the prescribed dosage regimen.
- Shake the bottle well before each use and avoid touching the dropper tip to any surface to prevent contamination.
Pregnancy and Breastfeeding
- Xalatan should be used during pregnancy only if the potential benefits outweigh the potential risks to the fetus.
- It is not recommended during breastfeeding due to limited data on its excretion into breast milk.
Dosage and Administration
The recommended dosage is one drop of Xalatan in the affected eye(s) once daily, preferably in the evening.
Overdose
In case of overdose, supportive measures should be initiated, and medical attention should be sought immediately. Symptoms of overdose may include ocular irritation, conjunctival hyperemia, and eye pain.
Side Effects
Common side effects of Xalatan may include:
- Ocular irritation (e.g., burning, stinging, itching)
- Conjunctival hyperemia (redness)
- Blurred vision
- Dry eye
- Foreign body sensation
Less common but more severe adverse reactions may include:
- Allergic reactions (e.g., rash, itching, swelling)
- Conjunctival follicles
- Eyelash growth
- Iris pigmentation
- Periorbital skin darkening
- Visual disturbances
If any of these side effects persist or worsen, patients should discontinue use and consult their healthcare provider promptly. Additionally, patients should seek medical attention if they experience any signs of systemic absorption, such as changes in heart rate, blood pressure, or mental status.